Canadian Management of Serous Tubal Intraepithelial Carcinoma

Management of serous tubal intraepithelial carcinoma varied across centers. The 5-year cumulative incidence of high-grade serous carcinoma after isolated serous tubal intraepithelial carcinoma was 5.7%, consistent with recent literature. However, multicenter pathology review revealed initial underdiagnosed high-grade serous carcinoma, and 5-year cumulative incidence of high-grade serous carcinoma after confirmed serous tubal intraepithelial carcinoma decreased to 2.6%, underscoring the importance of diagnostic confirmation by expert pathologists to guide accurate management.

Authors

Institutions

Publication Details

Journal
Obstetrics and Gynecology
Published
2025-07-24
DOI
https://doi.org/10.1097/aog.0000000000006016
Citations
4
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
6.79
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Canadian Management of Serous Tubal Intraepithelial Carcinoma

Tomer Feigenberg, Marcus Q. Bernardini, Marjan Rouzbahman, Diane Provencher et al.
4 citations
Obstetrics and Gynecology
Ovarian cancer diagnosis and treatment
6.79
article

Canadian Management of Serous Tubal Intraepithelial Carcinoma

Tomer Feigenberg, Marcus Q. Bernardini, Marjan Rouzbahman, Diane Provencher, Katharina Kieser, Sophia Pin, Walter H. Gotlieb, Alon D. Altman, Elisabeth Spénard, Katherine Grondin, Janice S. Kwon, Patti Power, A. T. Cameron, Lua Eiriksson, Ly-Ann Teo-Fortin, Danielle Vicus, Marie Plante, Kimberly Stewart, Michelle Jacobson, Lien Hoang, Ada Hsieh, Martin Köebel
article en
4 citations

Abstract

Management of serous tubal intraepithelial carcinoma varied across centers. The 5-year cumulative incidence of high-grade serous carcinoma after isolated serous tubal intraepithelial carcinoma was 5.7%, consistent with recent literature. However, multicenter pathology review revealed initial underdiagnosed high-grade serous carcinoma, and 5-year cumulative incidence of high-grade serous carcinoma after confirmed serous tubal intraepithelial carcinoma decreased to 2.6%, underscoring the importance of diagnostic confirmation by expert pathologists to guide accurate management.

Obstetrics and GynecologyVol. 146(3)
Gynecologic Oncology Group (US), Université du Québec à Montréal (CA)
Good health and well-being
Openalex Percentile: Top 3%
Ovarian cancer diagnosis and treatment
6.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Canadian Management of Serous Tubal Intraepithelial Carcinoma — Tomer Feigenberg, Marcus Q. Bernardini, et al. · Obstetrics and Gynecology (2025) | TGRS Research Map | TGRS